Related Experiment Video

Updated: Aug 4, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Mitochondrial cholesterol transport: a possible target in the management of hyperlipidemia

E A Hall1, S Ren, P B Hylemon

  • 1Department of Internal Medicine, Virginia Commonwealth University, USA.

Lipids
|February 16, 2006
PubMed

Insights

Sterol 27-hydroxylase (CYP27A1) activity influences cholesterol balance. Regulating mitochondrial cholesterol transport, not just enzyme expression, offers a potential therapeutic strategy for hyperlipidemia and atherosclerosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Diseases

Background:

  • Sterol 27-hydroxylase (CYP27A1) plays a role in cholesterol metabolism.
  • CYP27A1 is a potential therapeutic target for hyperlipidemia.

Purpose of the Study:

  • To investigate cholesterol homeostasis in response to altered CYP27A1 activity.
  • To compare the effects of increasing CYP27A1 expression versus substrate availability.

Main Methods:

  • Utilized HepG2 cells and primary human hepatocytes.
  • Manipulated CYP27A1 activity through enzyme expression and mitochondrial cholesterol transport.
  • Assessed bile acid synthesis, cholesterol levels, and regulatory protein/mRNA expression (HMGR, LDLR, SREBP).

Main Results:

  • Increased CYP27A1 expression led to increased bile acid synthesis, HMGR, and LDLR uptake, with minimal 27-hydroxycholesterol (27OH-Chol) increase.
  • Increased mitochondrial cholesterol transport resulted in higher bile acid and 27OH-Chol levels, decreased SREBP 2 and HMGR, but increased LDLR mRNA.
  • LDLR mRNA increased despite lower SREBP 2, suggesting alternative regulatory pathways.

Conclusions:

  • Regulation of liver mitochondrial cholesterol transport is a potential therapeutic strategy for hyperlipidemia.
  • CYP27A1 activity impacts cholesterol homeostasis through multiple pathways.
  • Alternative mechanisms may regulate LDLR transcription independently of SREBP 2.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...